Tamim Shaikh
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abnormalities, Multiple | 14 | 2015 | 178 | 2.370 |
Why?
| Chromosome Deletion | 16 | 2021 | 102 | 2.360 |
Why?
| DNA Copy Number Variations | 9 | 2023 | 169 | 1.730 |
Why?
| Chromosomes, Human, Pair 22 | 15 | 2019 | 41 | 1.470 |
Why?
| Repetitive Sequences, Nucleic Acid | 12 | 2019 | 111 | 1.230 |
Why?
| Craniofacial Abnormalities | 7 | 2021 | 63 | 1.180 |
Why?
| Oligonucleotide Array Sequence Analysis | 18 | 2011 | 755 | 1.150 |
Why?
| Gene Dosage | 12 | 2011 | 142 | 1.130 |
Why?
| Gene Duplication | 7 | 2011 | 67 | 1.080 |
Why?
| Vitamin B 12 | 3 | 2017 | 122 | 1.050 |
Why?
| Heart Defects, Congenital | 4 | 2021 | 747 | 1.040 |
Why?
| Host Cell Factor C1 | 3 | 2017 | 14 | 1.040 |
Why?
| Segmental Duplications, Genomic | 3 | 2023 | 7 | 1.030 |
Why?
| Chromosome Disorders | 3 | 2021 | 39 | 1.020 |
Why?
| Intellectual Disability | 5 | 2021 | 149 | 0.990 |
Why?
| Williams Syndrome | 2 | 2021 | 13 | 0.820 |
Why?
| Translocation, Genetic | 12 | 2011 | 95 | 0.810 |
Why?
| Chromosome Breakage | 10 | 2010 | 21 | 0.750 |
Why?
| Genomic Structural Variation | 1 | 2021 | 12 | 0.720 |
Why?
| Chromosome Mapping | 12 | 2023 | 504 | 0.720 |
Why?
| Polymorphism, Single Nucleotide | 18 | 2015 | 2059 | 0.700 |
Why?
| Zebrafish | 4 | 2020 | 464 | 0.660 |
Why?
| In Situ Hybridization, Fluorescence | 21 | 2019 | 313 | 0.660 |
Why?
| Developmental Disabilities | 7 | 2021 | 258 | 0.650 |
Why?
| Gene Deletion | 6 | 2011 | 369 | 0.640 |
Why?
| Repressor Proteins | 3 | 2017 | 399 | 0.610 |
Why?
| Chromosome Aberrations | 7 | 2018 | 148 | 0.600 |
Why?
| Mutation | 12 | 2021 | 3682 | 0.590 |
Why?
| Genetic Variation | 9 | 2016 | 933 | 0.570 |
Why?
| Vestibular Diseases | 2 | 2015 | 25 | 0.560 |
Why?
| Genetic Diseases, X-Linked | 2 | 2017 | 23 | 0.560 |
Why?
| Seizures | 1 | 2021 | 400 | 0.560 |
Why?
| Hematologic Diseases | 2 | 2015 | 60 | 0.560 |
Why?
| Chromosomes, Human, Pair 16 | 5 | 2021 | 30 | 0.500 |
Why?
| Chromosomes, Human, Pair 1 | 4 | 2010 | 70 | 0.500 |
Why?
| Genome, Human | 6 | 2021 | 390 | 0.480 |
Why?
| Histone Demethylases | 1 | 2015 | 31 | 0.480 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2015 | 30 | 0.470 |
Why?
| Chromosomes, Human, Pair 11 | 6 | 2003 | 56 | 0.460 |
Why?
| Neoplasm Proteins | 2 | 2015 | 419 | 0.460 |
Why?
| Face | 2 | 2015 | 164 | 0.450 |
Why?
| Molecular Sequence Data | 22 | 2015 | 2820 | 0.450 |
Why?
| Blepharophimosis | 1 | 2014 | 3 | 0.450 |
Why?
| Skin Abnormalities | 1 | 2014 | 12 | 0.450 |
Why?
| Frameshift Mutation | 1 | 2014 | 31 | 0.440 |
Why?
| DNA-Binding Proteins | 5 | 2015 | 1421 | 0.440 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2013 | 51 | 0.440 |
Why?
| Codon, Nonsense | 1 | 2014 | 39 | 0.440 |
Why?
| Brain Diseases | 1 | 2015 | 136 | 0.430 |
Why?
| Genes, X-Linked | 1 | 2013 | 17 | 0.430 |
Why?
| Hyperhomocysteinemia | 1 | 2013 | 26 | 0.430 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 2013 | 22 | 0.430 |
Why?
| Syndrome | 10 | 2023 | 332 | 0.420 |
Why?
| Base Sequence | 19 | 2017 | 2134 | 0.420 |
Why?
| Histone Acetyltransferases | 1 | 2014 | 63 | 0.410 |
Why?
| Zebrafish Proteins | 1 | 2014 | 269 | 0.370 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 385 | 0.370 |
Why?
| Chromosomes, Human, Pair 13 | 2 | 2009 | 14 | 0.360 |
Why?
| Sequence Deletion | 5 | 2011 | 178 | 0.360 |
Why?
| Chromosomes, Human, Pair 10 | 2 | 2011 | 18 | 0.360 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2014 | 817 | 0.350 |
Why?
| Epilepsy | 1 | 2015 | 322 | 0.350 |
Why?
| Chromosomes, Human, Pair 21 | 2 | 2011 | 42 | 0.350 |
Why?
| Carrier Proteins | 1 | 2014 | 730 | 0.340 |
Why?
| Genomics | 2 | 2023 | 714 | 0.340 |
Why?
| Nuclear Proteins | 1 | 2015 | 657 | 0.340 |
Why?
| Humans | 74 | 2023 | 128019 | 0.340 |
Why?
| Down Syndrome | 1 | 2016 | 469 | 0.340 |
Why?
| Phenotype | 14 | 2021 | 3039 | 0.330 |
Why?
| Infant | 19 | 2018 | 8912 | 0.320 |
Why?
| Databases, Genetic | 2 | 2010 | 228 | 0.310 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2008 | 48 | 0.310 |
Why?
| DNA Mutational Analysis | 7 | 2015 | 384 | 0.310 |
Why?
| Congenital Abnormalities | 1 | 2008 | 73 | 0.300 |
Why?
| Child | 21 | 2021 | 20636 | 0.290 |
Why?
| Autistic Disorder | 1 | 2010 | 185 | 0.280 |
Why?
| Genome-Wide Association Study | 7 | 2021 | 1330 | 0.270 |
Why?
| Genetic Predisposition to Disease | 7 | 2013 | 2261 | 0.260 |
Why?
| Child, Preschool | 18 | 2021 | 10378 | 0.260 |
Why?
| Nondisjunction, Genetic | 2 | 2010 | 3 | 0.260 |
Why?
| Branchial Region | 2 | 2017 | 35 | 0.250 |
Why?
| Meiosis | 2 | 2010 | 63 | 0.250 |
Why?
| Gene Knockdown Techniques | 3 | 2020 | 311 | 0.250 |
Why?
| Hyperglycinemia, Nonketotic | 2 | 2017 | 51 | 0.230 |
Why?
| DiGeorge Syndrome | 4 | 2015 | 29 | 0.230 |
Why?
| Amino Acid Sequence | 4 | 2020 | 2042 | 0.230 |
Why?
| Primates | 5 | 2019 | 118 | 0.230 |
Why?
| Rhabdoid Tumor | 4 | 2009 | 97 | 0.210 |
Why?
| Polymerase Chain Reaction | 8 | 2011 | 1020 | 0.210 |
Why?
| Gene Amplification | 4 | 2001 | 103 | 0.210 |
Why?
| Sequence Alignment | 6 | 2015 | 329 | 0.210 |
Why?
| Models, Genetic | 5 | 2011 | 591 | 0.190 |
Why?
| Genetic Association Studies | 3 | 2020 | 361 | 0.190 |
Why?
| Genetic Diseases, Inborn | 1 | 2001 | 38 | 0.180 |
Why?
| Tanzania | 1 | 2021 | 44 | 0.180 |
Why?
| Chromosome Breakpoints | 1 | 2021 | 6 | 0.180 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2021 | 56 | 0.180 |
Why?
| Transcription, Genetic | 2 | 2017 | 1403 | 0.180 |
Why?
| Forkhead Transcription Factors | 2 | 2014 | 181 | 0.180 |
Why?
| Male | 25 | 2021 | 62757 | 0.180 |
Why?
| DNA, Complementary | 2 | 1999 | 266 | 0.170 |
Why?
| Animals | 16 | 2020 | 34487 | 0.170 |
Why?
| 22q11 Deletion Syndrome | 1 | 2019 | 2 | 0.170 |
Why?
| Spasms, Infantile | 1 | 2021 | 121 | 0.160 |
Why?
| Genotype | 8 | 2015 | 1828 | 0.160 |
Why?
| Receptors, GABA-A | 1 | 2020 | 97 | 0.160 |
Why?
| Karyotyping | 5 | 2018 | 107 | 0.160 |
Why?
| Protein Subunits | 1 | 2020 | 230 | 0.160 |
Why?
| Nucleic Acid Hybridization | 3 | 2007 | 188 | 0.150 |
Why?
| Prader-Willi Syndrome | 2 | 2013 | 27 | 0.150 |
Why?
| Holoprosencephaly | 1 | 2018 | 8 | 0.150 |
Why?
| Cell Cycle Proteins | 2 | 1999 | 578 | 0.150 |
Why?
| Cell Differentiation | 2 | 2017 | 1896 | 0.150 |
Why?
| Sequence Homology, Nucleic Acid | 6 | 2008 | 150 | 0.150 |
Why?
| RNA Polymerase III | 1 | 1997 | 25 | 0.140 |
Why?
| Chromosomal Proteins, Non-Histone | 2 | 2009 | 115 | 0.140 |
Why?
| AT Rich Sequence | 3 | 2010 | 4 | 0.140 |
Why?
| Methylmalonic Acid | 1 | 2017 | 62 | 0.140 |
Why?
| Primary Cell Culture | 1 | 2017 | 157 | 0.130 |
Why?
| Gene Expression Regulation | 3 | 2017 | 2508 | 0.130 |
Why?
| Sequence Analysis, DNA | 5 | 2011 | 771 | 0.130 |
Why?
| Cohort Studies | 2 | 2021 | 5378 | 0.130 |
Why?
| Vitamin B 12 Deficiency | 1 | 2017 | 78 | 0.130 |
Why?
| Polymorphism, Genetic | 4 | 2005 | 638 | 0.130 |
Why?
| Glycine | 1 | 2017 | 163 | 0.130 |
Why?
| Glucose Transporter Type 3 | 1 | 2015 | 13 | 0.120 |
Why?
| Aminoacylation | 1 | 2015 | 12 | 0.120 |
Why?
| Motor Activity | 1 | 2020 | 667 | 0.120 |
Why?
| DNA Probes | 2 | 2008 | 61 | 0.120 |
Why?
| Chromosomal Instability | 2 | 2019 | 18 | 0.120 |
Why?
| Female | 21 | 2021 | 68016 | 0.120 |
Why?
| Heterozygote | 5 | 2020 | 267 | 0.120 |
Why?
| Gene Expression | 1 | 2020 | 1454 | 0.120 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 231 | 0.110 |
Why?
| Forkhead Box Protein L2 | 1 | 2014 | 2 | 0.110 |
Why?
| Oxidoreductases | 1 | 2014 | 89 | 0.110 |
Why?
| RNA, Transfer | 1 | 2015 | 130 | 0.110 |
Why?
| Sulfurtransferases | 1 | 2013 | 9 | 0.110 |
Why?
| Glutaredoxins | 1 | 2013 | 12 | 0.110 |
Why?
| Exome | 1 | 2015 | 220 | 0.110 |
Why?
| Body Patterning | 1 | 2014 | 128 | 0.110 |
Why?
| Neural Crest | 1 | 2014 | 114 | 0.110 |
Why?
| Inverted Repeat Sequences | 2 | 2010 | 19 | 0.110 |
Why?
| Urogenital Abnormalities | 1 | 2014 | 52 | 0.110 |
Why?
| Hypothyroidism | 1 | 2013 | 70 | 0.100 |
Why?
| Infant, Newborn | 4 | 2017 | 5688 | 0.100 |
Why?
| Green Fluorescent Proteins | 1 | 2014 | 380 | 0.100 |
Why?
| Comparative Genomic Hybridization | 4 | 2018 | 32 | 0.100 |
Why?
| Elastin | 1 | 2013 | 77 | 0.100 |
Why?
| Mosaicism | 2 | 2010 | 71 | 0.100 |
Why?
| Microarray Analysis | 2 | 2010 | 120 | 0.100 |
Why?
| Mental Disorders | 1 | 2021 | 1005 | 0.100 |
Why?
| Chondrocytes | 1 | 2014 | 203 | 0.100 |
Why?
| Proteins | 2 | 2013 | 933 | 0.100 |
Why?
| Fibroblasts | 1 | 2017 | 934 | 0.100 |
Why?
| Nucleic Acid Amplification Techniques | 2 | 2009 | 32 | 0.100 |
Why?
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 3 | 0.100 |
Why?
| Philadelphia | 1 | 2011 | 45 | 0.100 |
Why?
| Age of Onset | 1 | 2013 | 490 | 0.090 |
Why?
| Nerve Growth Factors | 1 | 2011 | 73 | 0.090 |
Why?
| Alleles | 4 | 2020 | 842 | 0.090 |
Why?
| RNA, Small Interfering | 1 | 2013 | 569 | 0.090 |
Why?
| HEK293 Cells | 1 | 2013 | 681 | 0.090 |
Why?
| Alu Elements | 2 | 2000 | 27 | 0.090 |
Why?
| Child Development Disorders, Pervasive | 1 | 2011 | 61 | 0.090 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2010 | 35 | 0.090 |
Why?
| Cloning, Molecular | 3 | 2005 | 522 | 0.080 |
Why?
| Binding Sites | 1 | 2013 | 1241 | 0.080 |
Why?
| Stem Cells | 1 | 2014 | 577 | 0.080 |
Why?
| Transcription Factors | 2 | 2009 | 1628 | 0.080 |
Why?
| Cell Movement | 1 | 2014 | 933 | 0.080 |
Why?
| Base Pairing | 1 | 2009 | 61 | 0.080 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2009 | 16 | 0.080 |
Why?
| Mice, Transgenic | 1 | 2014 | 2066 | 0.080 |
Why?
| Blindness, Cortical | 1 | 2008 | 5 | 0.080 |
Why?
| Hematologic Neoplasms | 1 | 2011 | 140 | 0.080 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2008 | 15 | 0.080 |
Why?
| Synaptic Transmission | 1 | 2011 | 258 | 0.080 |
Why?
| DNA, Circular | 1 | 2008 | 15 | 0.080 |
Why?
| Evolution, Molecular | 2 | 2019 | 463 | 0.080 |
Why?
| DNA Primers | 5 | 2003 | 509 | 0.080 |
Why?
| RNA, Messenger | 2 | 2013 | 2669 | 0.070 |
Why?
| Cleft Lip | 1 | 2008 | 44 | 0.070 |
Why?
| Gene Silencing | 1 | 2009 | 183 | 0.070 |
Why?
| Molecular Probe Techniques | 1 | 2008 | 9 | 0.070 |
Why?
| Haploinsufficiency | 3 | 2013 | 48 | 0.070 |
Why?
| Brain | 3 | 2017 | 2615 | 0.070 |
Why?
| Neuroblastoma | 1 | 2009 | 153 | 0.070 |
Why?
| Beckwith-Wiedemann Syndrome | 1 | 2007 | 6 | 0.070 |
Why?
| Astrocytoma | 1 | 2008 | 120 | 0.070 |
Why?
| Hernia, Diaphragmatic | 1 | 2007 | 69 | 0.070 |
Why?
| DNA | 4 | 2010 | 1392 | 0.070 |
Why?
| Synapses | 1 | 2011 | 383 | 0.070 |
Why?
| Protein Binding | 1 | 2013 | 2105 | 0.070 |
Why?
| Central Nervous System | 1 | 2009 | 254 | 0.070 |
Why?
| Nerve Tissue Proteins | 1 | 2011 | 569 | 0.070 |
Why?
| Young Adult | 3 | 2018 | 12281 | 0.070 |
Why?
| Cleft Palate | 1 | 2007 | 58 | 0.070 |
Why?
| Oncogene Proteins, Fusion | 1 | 2008 | 198 | 0.070 |
Why?
| Gene Frequency | 4 | 2013 | 504 | 0.070 |
Why?
| Proto-Oncogene Proteins B-raf | 1 | 2008 | 212 | 0.070 |
Why?
| Learning | 1 | 2010 | 393 | 0.070 |
Why?
| Pulmonary Alveoli | 1 | 2009 | 365 | 0.070 |
Why?
| Teratoma | 1 | 2007 | 103 | 0.070 |
Why?
| Research Design | 2 | 2009 | 1034 | 0.060 |
Why?
| Genes, Neurofibromatosis 1 | 1 | 2005 | 4 | 0.060 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2005 | 9 | 0.060 |
Why?
| Computational Biology | 1 | 2010 | 595 | 0.060 |
Why?
| Adult | 8 | 2015 | 35176 | 0.060 |
Why?
| Schizophrenia | 1 | 2009 | 428 | 0.060 |
Why?
| Nucleic Acid Conformation | 1 | 2008 | 706 | 0.060 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 395 | 0.060 |
Why?
| Conserved Sequence | 1 | 2005 | 227 | 0.060 |
Why?
| Trisomy | 1 | 2005 | 77 | 0.060 |
Why?
| Gene Expression Profiling | 1 | 2011 | 1681 | 0.060 |
Why?
| Biological Evolution | 4 | 1996 | 425 | 0.060 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2009 | 374 | 0.060 |
Why?
| Chromosome Fragile Sites | 1 | 2003 | 1 | 0.060 |
Why?
| Mice, Knockout | 1 | 2010 | 2757 | 0.060 |
Why?
| Chromosomes, Human, 21-22 and Y | 1 | 2003 | 4 | 0.050 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2003 | 28 | 0.050 |
Why?
| Genetic Testing | 2 | 2011 | 428 | 0.050 |
Why?
| Dinucleotide Repeats | 1 | 2003 | 4 | 0.050 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2003 | 54 | 0.050 |
Why?
| Adolescent | 8 | 2018 | 20158 | 0.050 |
Why?
| Cell Line | 4 | 2019 | 2736 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 940 | 0.050 |
Why?
| DNA Transposable Elements | 2 | 1995 | 118 | 0.050 |
Why?
| Mice | 4 | 2011 | 16574 | 0.050 |
Why?
| Consensus Sequence | 3 | 1997 | 72 | 0.050 |
Why?
| Hereditary Sensory and Motor Neuropathy | 1 | 2001 | 1 | 0.050 |
Why?
| Angelman Syndrome | 1 | 2001 | 11 | 0.050 |
Why?
| Chromosomes, Human | 1 | 2001 | 41 | 0.050 |
Why?
| Genetic Markers | 2 | 1999 | 338 | 0.050 |
Why?
| Charcot-Marie-Tooth Disease | 1 | 2001 | 21 | 0.050 |
Why?
| Haplotypes | 1 | 2023 | 471 | 0.050 |
Why?
| Adrenocorticotropic Hormone | 1 | 2021 | 133 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2010 | 3936 | 0.040 |
Why?
| Recombination, Genetic | 1 | 2001 | 189 | 0.040 |
Why?
| Pan paniscus | 1 | 2000 | 4 | 0.040 |
Why?
| Contig Mapping | 1 | 2000 | 10 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 123 | 0.040 |
Why?
| Physical Chromosome Mapping | 1 | 1999 | 17 | 0.040 |
Why?
| Gorilla gorilla | 1 | 2000 | 22 | 0.040 |
Why?
| Time Factors | 2 | 2008 | 6479 | 0.040 |
Why?
| Brain Neoplasms | 1 | 2008 | 1163 | 0.040 |
Why?
| HeLa Cells | 2 | 2000 | 605 | 0.040 |
Why?
| Follow-Up Studies | 1 | 2008 | 4853 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2000 | 930 | 0.040 |
Why?
| Macaca mulatta | 1 | 2000 | 147 | 0.040 |
Why?
| Enhancer Elements, Genetic | 1 | 2000 | 176 | 0.040 |
Why?
| Locomotion | 1 | 2020 | 98 | 0.040 |
Why?
| Larva | 1 | 2020 | 212 | 0.040 |
Why?
| Phylogeny | 2 | 2001 | 838 | 0.040 |
Why?
| Family Health | 1 | 1999 | 194 | 0.040 |
Why?
| Cytogenetics | 1 | 2018 | 12 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 367 | 0.040 |
Why?
| Cosmids | 1 | 1997 | 5 | 0.040 |
Why?
| SMARCB1 Protein | 2 | 2009 | 29 | 0.040 |
Why?
| Chromosomes, Artificial, Bacterial | 2 | 2010 | 17 | 0.040 |
Why?
| Carcinoma, Embryonal | 1 | 1997 | 2 | 0.040 |
Why?
| DNA Replication | 1 | 1999 | 225 | 0.030 |
Why?
| Oligodeoxyribonucleotides | 1 | 1997 | 138 | 0.030 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1997 | 63 | 0.030 |
Why?
| Cytoplasm | 1 | 1997 | 257 | 0.030 |
Why?
| Random Allocation | 1 | 1997 | 342 | 0.030 |
Why?
| Cardiovascular Diseases | 1 | 2008 | 1994 | 0.030 |
Why?
| Cells, Cultured | 3 | 2011 | 4006 | 0.030 |
Why?
| Recurrence | 2 | 2010 | 993 | 0.030 |
Why?
| Pedigree | 2 | 2010 | 485 | 0.030 |
Why?
| Cell Nucleus | 1 | 1997 | 579 | 0.030 |
Why?
| Plasmids | 2 | 2008 | 354 | 0.030 |
Why?
| RNA | 1 | 2000 | 881 | 0.030 |
Why?
| Hominidae | 1 | 1994 | 81 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2013 | 2703 | 0.030 |
Why?
| Endocrine System | 1 | 2013 | 20 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 170 | 0.030 |
Why?
| Aortic Stenosis, Supravalvular | 1 | 2013 | 4 | 0.030 |
Why?
| Chromosome Banding | 2 | 2005 | 21 | 0.030 |
Why?
| Fatal Outcome | 1 | 2013 | 299 | 0.030 |
Why?
| Case-Control Studies | 2 | 2011 | 3324 | 0.030 |
Why?
| Prognosis | 2 | 2011 | 3766 | 0.030 |
Why?
| Aorta, Thoracic | 1 | 2015 | 260 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2017 | 1408 | 0.020 |
Why?
| Penetrance | 1 | 2011 | 27 | 0.020 |
Why?
| Homologous Recombination | 1 | 2011 | 23 | 0.020 |
Why?
| Gene Order | 1 | 2011 | 26 | 0.020 |
Why?
| Mitochondrial Proteins | 1 | 2013 | 245 | 0.020 |
Why?
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2011 | 1 | 0.020 |
Why?
| Sclerosis | 1 | 2011 | 12 | 0.020 |
Why?
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2011 | 8 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 16 | 0.020 |
Why?
| Collagen Type VI | 1 | 2011 | 5 | 0.020 |
Why?
| Monosomy | 1 | 2010 | 11 | 0.020 |
Why?
| Genotyping Techniques | 1 | 2011 | 72 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 69 | 0.020 |
Why?
| Muscular Dystrophies | 1 | 2011 | 34 | 0.020 |
Why?
| Spermatogenesis | 1 | 2010 | 62 | 0.020 |
Why?
| Health | 1 | 2010 | 73 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2010 | 146 | 0.020 |
Why?
| Spermatozoa | 1 | 2010 | 91 | 0.020 |
Why?
| Receptor, Metabotropic Glutamate 5 | 1 | 2009 | 5 | 0.020 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2009 | 10 | 0.020 |
Why?
| Jagged-1 Protein | 1 | 2009 | 22 | 0.020 |
Why?
| Serrate-Jagged Proteins | 1 | 2009 | 27 | 0.020 |
Why?
| Loss of Heterozygosity | 1 | 2009 | 46 | 0.020 |
Why?
| Ultrasonography | 1 | 2013 | 708 | 0.020 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2009 | 39 | 0.020 |
Why?
| Capillaries | 1 | 2009 | 91 | 0.020 |
Why?
| Alagille Syndrome | 1 | 2009 | 33 | 0.020 |
Why?
| Genes, Tumor Suppressor | 1 | 2009 | 86 | 0.020 |
Why?
| Concept Formation | 1 | 2008 | 30 | 0.020 |
Why?
| Population Groups | 1 | 2008 | 58 | 0.020 |
Why?
| Quality Control | 1 | 2008 | 156 | 0.020 |
Why?
| Coloboma | 1 | 2008 | 4 | 0.020 |
Why?
| Hybrid Cells | 2 | 2000 | 50 | 0.020 |
Why?
| Pulmonary Veins | 1 | 2009 | 93 | 0.020 |
Why?
| Models, Biological | 2 | 2008 | 1689 | 0.020 |
Why?
| Calcium-Binding Proteins | 1 | 2009 | 209 | 0.020 |
Why?
| Doxorubicin | 1 | 2009 | 322 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 371 | 0.020 |
Why?
| Proto-Oncogene Proteins | 1 | 2011 | 632 | 0.020 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 304 | 0.020 |
Why?
| Blotting, Western | 1 | 2008 | 1169 | 0.020 |
Why?
| DNA, Cruciform | 1 | 2005 | 4 | 0.020 |
Why?
| Biomarkers | 1 | 2017 | 3874 | 0.020 |
Why?
| Family | 1 | 2010 | 648 | 0.020 |
Why?
| COS Cells | 1 | 2005 | 184 | 0.020 |
Why?
| Genomic Instability | 1 | 2005 | 47 | 0.020 |
Why?
| Fetus | 1 | 2009 | 760 | 0.010 |
Why?
| Primed In Situ Labeling | 1 | 2003 | 1 | 0.010 |
Why?
| Neurofibromin 1 | 1 | 2003 | 25 | 0.010 |
Why?
| Centromere | 1 | 2003 | 48 | 0.010 |
Why?
| Membrane Proteins | 1 | 2009 | 1105 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1609 | 0.010 |
Why?
| Introns | 1 | 2003 | 249 | 0.010 |
Why?
| Exons | 1 | 2003 | 338 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2009 | 3009 | 0.010 |
Why?
| Lymphocytes | 1 | 2003 | 367 | 0.010 |
Why?
| DNA, Recombinant | 1 | 2000 | 46 | 0.010 |
Why?
| Blotting, Northern | 1 | 2000 | 198 | 0.010 |
Why?
| Chromosome Fragility | 1 | 2000 | 2 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 151 | 0.010 |
Why?
| Telomere | 1 | 2003 | 226 | 0.010 |
Why?
| Obesity | 1 | 2013 | 2859 | 0.010 |
Why?
| Mutagenesis | 1 | 2000 | 181 | 0.010 |
Why?
| RNA Stability | 1 | 2000 | 100 | 0.010 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 1999 | 43 | 0.010 |
Why?
| Prospective Studies | 1 | 2011 | 7035 | 0.010 |
Why?
| Sequence Tagged Sites | 1 | 1997 | 4 | 0.010 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.010 |
Why?
| Chromosomes, Bacterial | 1 | 1997 | 8 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2007 | 2509 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 431 | 0.010 |
Why?
| Bacteriophages | 1 | 1997 | 92 | 0.010 |
Why?
| Sequence Analysis | 1 | 1995 | 37 | 0.010 |
Why?
| Risk Factors | 1 | 2009 | 9696 | 0.010 |
Why?
| Mutagenesis, Insertional | 1 | 1995 | 65 | 0.010 |
Why?
| Rodentia | 1 | 1995 | 47 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 69 | 0.010 |
Why?
| Africa | 1 | 1994 | 98 | 0.010 |
Why?
| Treatment Outcome | 1 | 2007 | 10110 | 0.010 |
Why?
| Middle Aged | 1 | 2013 | 30812 | 0.010 |
Why?
| Species Specificity | 1 | 1990 | 568 | 0.010 |
Why?
|
|
Shaikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|